J. Cambronero

Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial

Vik Khullar, G. Amarenco, J.C. Angulo et al. · European Urology · 2012 · 416 citations

Urological Research, Urology, Voiding Dysfunction +6

Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double‐blind, placebo‐controlled, phase <scp>III</scp> studies

V. Khullar, Philip E.V. van Kerrebroeck, Sender Herschorn et al. · International Journal of Clinical Practice · 2013 · 206 citations · Full text

Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)

Marcus J. Drake, Christopher R. Chapple, Adil Esen et al. · European Urology · 2016 · 181 citations · Full text

Radiologic Findings of Segmental Testicular Infarction

G. C. Fernández-Pérez, Francisco Tardáguila, María José Martín Velasco et al. · American Journal of Roentgenology · 2005 · 146 citations

The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial

José E. Batista, H. Kölbl, Sender Herschorn et al. · Therapeutic Advances in Urology · 2015 · 83 citations · Full text